Share →

The Rosen Law Firm, a global investor rights law firm, announces that it has filed a class action lawsuit on behalf of purchasers of Avalanche Biotechnologies, Inc. AAVL, +1.85% securities (1) pursuant and/or traceable to the Company’s Initial Public Offering on or about July 31, 2014; and/or (2) on the open market between July 31, 2014 and June 15, 2015, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for Avalanche Biotechnologies investors under the federal securities laws.

Source: EQUITY ALERT: The Rosen Law Firm Files Securities Class Action Lawsuit Against Avalanche Biotechnologies, Inc. – MarketWatch